Vedanta Biosciences

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. It includes a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally defined bacterial consortia in powder form to help physicians have access to live bacteria drugs to treat autoimmune and inflammatory diseases easily.

Vedanta Biosciences headquartered in United States, North America, operates in the Biotechnology, Business Development, Medical sector. The company focuses on Biotechnology and has secured $89.1B in funding across 204 round(s). With a team of 101-250 employees, Vedanta Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Private Equity Round - Vedanta Biosciences, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.